LifeStance Health Group, Inc.
LFSTNASDAQHealthcare● Active
$7.41
$-0.23(-3.01%)
Market Cap$2.9B
P/E Ratio—
52W High$8.89
52W Low$3.74
LifeStance Health Group, Inc. (LFST) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · LFST · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.42B | $1.25B | $1.06B | $0.86B | $0.67B |
| Cost of Revenue | $1.02B | $0.85B | $0.75B | $0.62B | $0.47B |
| Gross Profit | $0.41B | $0.40B | $0.30B | $0.24B | $0.20B |
| Gross Margin %(computed) | 28.53% | 32.17% | 28.62% | 27.57% | 30.19% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.38B | $0.36B | $0.41B | $0.38B | $0.43B |
| Total Operating Expenses | $0.38B | $0.43B | $0.49B | $0.45B | $0.49B |
| Operating Income | $0.03B | ($0.03B) | ($0.19B) | ($0.21B) | ($0.29B) |
| Operating Margin %(computed) | 1.80% | -2.53% | -17.92% | -24.45% | -42.90% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.01B | $0.03B | $0.02B | $0.02B | $0.04B |
| Income Before Tax | $0.01B | ($0.06B) | ($0.21B) | ($0.23B) | ($0.33B) |
| Income Tax Expense | $0.00B | ($0.00B) | ($0.02B) | ($0.02B) | ($0.03B) |
| Net Income | $0.01B | ($0.06B) | ($0.19B) | ($0.22B) | ($0.31B) |
| Net Margin %(computed) | 0.68% | -4.59% | -17.64% | -25.08% | -46.02% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.03 | $-0.15 | $-0.51 | $-0.61 | $-1.05 |
| Wtd Avg Shares | 0.39B | 0.38B | 0.37B | 0.36B | 0.33B |
| EBITDA | $0.08B | $0.04B | ($0.10B) | ($0.14B) | ($0.24B) |
| EBITDA Margin %(computed) | 5.53% | 3.19% | -9.94% | -16.71% | -35.96% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more LifeStance Health Group, Inc. data
About LifeStance Health Group, Inc. (LFST) Income Statement
LifeStance Health Group, Inc. (LFST) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, LFST reported revenue of $1.42B, gross profit of $0.41B (gross margin 28.53%), and net income of $0.01B — a net profit margin of 0.68%.
Frequently asked questions
LFST · 4 questionsLifeStance Health Group, Inc. (LFST) reported revenue of $1.42B for 2025, up 13.9% year-over-year.
LFST revenueLFST salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08